Use of a Physiologically Based Pharmacokinetic Model for Rats to Study the Influence of Body Fat Mass and Induction of CYP1A2 on the Pharmacokinetics of TCDD

類似資料

• Comparison of the Use of a Physiologically Based Pharmacokinetic Model and a Classical Pharmacokinetic Model for Dioxin Exposure Assessments
  著者:: Emond, Claude, 等
  出版事項: (2005)
• The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling
  著者:: Emond, Claude, 等
  出版事項: (2018)
• Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals.
  著者:: DeVito, M J, 等
  出版事項: (1995)
• Proposed Mechanistic Description of Dose-Dependent BDE-47 Urinary Elimination in Mice Using a Physiologically Based Pharmacokinetic Model
  著者:: Emond, Claude, 等
  出版事項: (2013)
• Dietary Fat Alters Body Composition, Mammary Development, and Cytochrome P450 Induction after Maternal TCDD Exposure in DBA/2J Mice with Low-Responsive Aryl Hydrocarbon Receptors
  著者:: La Merrill, Michele, 等
  出版事項: (2009)